Browsing by Author Univ Hosp Bellvitge

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 12 of 12
Issue DateTitleAuthor(s)
1-Sep-20113-Year Safety Profile of Belatacept in Kidney Transplant Recipients from the BENEFIT and BENEFIT-EXT StudiesCharpentier, Bernard; Grinyo, Josep; Pestana, Jose Osmar Medina [UNIFESP]; Vanrenterghem, Yves; Vincenti, Flavio; Dong, Yuping; Thomas, Dolca; Larsen, Christian P.; Hop Bicetre; Univ Hosp Bellvitge; Universidade Federal de São Paulo (UNIFESP); Univ Hosp Leuven; UCSF Kidney Transplant Serv; Bristol Myers Squibb Co; Emory Univ
1-Apr-2010Belatacept vs Cyclosporine in ECD Kidney Transplants: Two-Year Outcomes from the BENEFIT-EXT StudyDurrbach, A.; Larsen, C. P.; Pestana, J. Medina [UNIFESP]; Vanrenterghem, Y.; Vincenti, F.; Florman, S.; Xing, J.; Block, A.; Garg, P.; Grinyo, J.; Hop Bicetre; Emory Univ; Universidade Federal de São Paulo (UNIFESP); Univ Hosp Leuven; UCSF; Mt Sinai Med Ctr; Bristol Myers Squibb Co; Univ Hosp Bellvitge
1-Apr-2010Belatacept vs Cyclosporine in Kidney Transplant Recipients: Two-Year Outcomes from the BENEFIT StudyLarsen, C. P.; Grinyo, J.; Charpentier, B.; Pestana, J. Medina [UNIFESP]; Kamar, N.; Vanrenterghem, Y.; Lin, C. -S.; Di Russo, G.; Garg, P.; Vincenti, F.; Emory Univ; Univ Hosp Bellvitge; Hop Bicetre; Universidade Federal de São Paulo (UNIFESP); Univ Hosp Toulouse; Univ Hosp Leuven; Bristol Myers Squibb Co; UCSF
15-May-2011Belatacept-Based Regimens Are Associated With Improved Cardiovascular and Metabolic Risk Factors Compared With Cyclosporine in Kidney Transplant Recipients (BENEFIT and BENEFIT-EXT Studies)Vanrenterghem, Yves; Bresnahan, Barbara; Campistol, Josep; Durrbach, Antoine; Grinyo, Josep; Neumayer, Hans-Hellmut; Lang, Philippe; Larsen, Christian P.; Mancilla-Urrea, Eduardo; Pestana, Jose Medina [UNIFESP]; Block, Alan; Duan, Tao; Glicklich, Alan; Gujrathi, Sheila; Vincenti, Flavio; Univ Hosp Leuven; Med Coll Wisconsin; Univ Barcelona; Univ Paris 11; Univ Hosp Bellvitge; Univ Med; Hosp Henri Mondor; Emory Univ; Inst Nacl Cardiol Dr Ignacio Chavez; Universidade Federal de São Paulo (UNIFESP); Bristol Myers Squibb Co; Univ Calif San Francisco
27-Dec-2010Belatacept-Based Regimens Versus a Cyclosporine A-Based Regimen in Kidney Transplant Recipients: 2-Year Results From the BENEFIT and BENEFIT-EXT StudiesLarsen, Christian P.; Grinyo, Josep; Medina-Pestana, Jose [UNIFESP]; Vanrenterghem, Yves; Vincenti, Flavio; Breshahan, Barbara; Campistol, Josep M.; Florman, Sander; del Carmen Rial, Maria; Kamar, Nassim; Block, Alan; Di Russo, Gregory; Lin, Chen-Sheng; Garg, Pushkal; Charpentier, Bernard; Emory Univ; Univ Hosp Bellvitge; Universidade Federal de São Paulo (UNIFESP); Univ Hosp Leuven; Univ Calif San Francisco; Med Coll Wisconsin; Univ Barcelona; Mt Sinai Med Ctr; Inst Nefrol; CHU Rangueil; Bristol Myers Squibb Co; Univ Paris S 11
15-Jan-2008Impulse control disorders in women with eating disordersFernandez-Aranda, Fernando; Poyastro Pinheiro, Andrea [UNIFESP]; Thornton, Laura M.; Berrettini, Wade H.; Crow, Scott; Fichter, Manfred M.; Halmi, Katherine A.; Kaplan, Allan S.; Keel, Pamela; Mitchell, James; Rotondo, Alessandro; Strober, Michael; Woodside, D. Blake; Kaye, Walter H.; Bulik, Cynthia M.; Univ N Carolina; Univ Hosp Bellvitge; Inst Salud Carlos III; Universidade Federal de São Paulo (UNIFESP); Univ Pittsburgh; Univ Penn; Univ Minnesota; Univ Munich; Cornell Univ; Toronto Hosp; Univ Iowa; Neuropsychiat Res Inst; Univ Pisa; Univ Calif Los Angeles
1-Aug-2009One year safety profile of belatacept in kidney transplant patients from the benefit and benefit-ext studiesLarsen, Christian; Charpentier, Bernard; Grinyo, Josep M.; Pestana, Jose Osmar Medina [UNIFESP]; Vanrenterghem, Yves; Vincenti, Flavio; Thomas, D.; Di Russo, Gregory B.; Shi, R.; Emory Univ; Hop Bicetre; Univ Hosp Bellvitge; Universidade Federal de São Paulo (UNIFESP); Univ Hosp Kuleuven; Univ Calif San Francisco; Bristol Myers Squibb Co
1-Apr-2010Outcomes as a Function of Donor Criteria from a Phase III Study of Belatacept vs Cyclosporine in Kidney Transplantation (BENEFIT-EXT).Florman, Sander; Durrbach, Antoine; Larsen, Christian; Pestana, Jose Osmar Medina [UNIFESP]; Vanrenterghem, Yves; Vincenti, Flavio; Block, Alan; Garg, Pushkal; Copley, J. Brian; Xing, Jun; Grinyo, Josep; Mt Sinai Med Ctr; Emory Univ; Universidade Federal de São Paulo (UNIFESP); Univ Hosp Leuven; UCSF; Bristol Myers Squibb Co; Univ Hosp Bellvitge
1-Mar-2010A Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT-EXT Study)Durrbach, A.; Pestana, Jose Osmar Medina [UNIFESP]; Pearson, T.; Vincenti, F.; Garcia, V. D.; Campistol, J.; del Carmen Rial, M.; Florman, S.; Block, A.; Di Russo, G.; Xing, J.; Garg, P.; Grinyo, J.; Univ Paris 11; Universidade Federal de São Paulo (UNIFESP); Emory Univ; Univ Calif San Francisco; Complexo Hosp Santa Casa; Univ Barcelona; Inst Nefrol; Tulane Sch Med; Bristol Myers Squibb Co; Univ Hosp Bellvitge
1-Aug-2009Primary outcomes from a randomized, Phase III study of belatacept vs cyclosporine in ECD kidney transplants (BENEFIT-EXT Study)Durrbach, Antoine; Larsen, Christian P.; Pestana, Jose Osmar Medina [UNIFESP]; Vanrenterghem, Yves; Vincenti, Flavio; Florman, Sander; Block, A. J.; Garg, Pushkal; Sen, K.; Grinyo, Josep M.; Univ Paris 11; Emory Univ; Universidade Federal de São Paulo (UNIFESP); Univ Hosp Kuleuven; Univ Calif San Francisco; Tulane Univ Med Ctr Hosp & Clin; Univ Hosp Bellvitge; Bristol Myers Squibb Co
1-Aug-2009Primary Outcomes from a Randomized, Phase III Study of Belatacept vs Cyclosporine in Kidney Transplant Recipients (BENEFIT Study)Vincenti, Flavio; Grinyo, Josep M.; Charpentier, Bernard; Pestana, Jose Osmar Medina [UNIFESP]; Rostaing, Lionel; Vanrenterghem, Yves; Di Russo, Gregory B.; Garg, Pushkal; Lin, Chen-Sheng; Larsen, Christian; Univ Calif San Francisco; Univ Hosp Bellvitge; Hop Bicetre; Universidade Federal de São Paulo (UNIFESP); CHU Rangueil; Univ Hosp Kuleuven; Bristol Myers Squibb Co; Emory Univ
1-Mar-2012Three-Year Outcomes From BENEFIT-EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor KidneysPestana, Jose Osmar Medina [UNIFESP]; Grinyo, J. M.; Vanrenterghem, Y.; Becker, T.; Campistol, J. M.; Florman, S.; Garcia, V. D.; Kamar, N.; Lang, P.; Manfro, R. C.; Massari, P.; Rial, M. D. C.; Schnitzler, M. A.; Vitko, S.; Duan, T.; Block, A.; Harler, M. B.; Durrbach, A.; Universidade Federal de São Paulo (UNIFESP); Univ Hosp Bellvitge; Univ Hosp Leuven; Hannover Med Sch; Univ Barcelona; Mt Sinai Med Ctr; Hosp Dom Vicente Scherer; CHU Rangueil; Univ Paris Est; Hosp Clin Porto Alegre; Hosp Privado Ctr Med Cordoba; Inst Nefrol; St Louis Univ; Inst Clin & Expt Med; Bristol Myers Squibb Co; Univ Paris 11